Showing results (71-80 of 238) with videos related to

Sort By:
Pageof 24
Chemotherapy|April 2, 2011
Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trialStefano Cereda, Michele Reni, Alessia Rognone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2013
Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinomaGiovanni M Cattaneo, Paolo Passoni, Barbara Longobardi, et al.
Glia|April 10, 2014
The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directionsFilippo Gagliardi, Ashwin Narayanan, Michele Reni, et al.
Lancet (London, England)|November 23, 2025
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trialMichele Reni, Marina Macchini, Giulia Orsi, et al.
Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy|March 15, 2022
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients?Giuseppe Vanella, Giuseppe Dell'Anna, Michiel Bronswijk, et al.
Thoracic Cancer|April 7, 2017
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic casesMaria C Mengoli, Giulia Orsi, Filippo Lococo, et al.
Cancer|September 5, 2002
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysisGiovanni Luca Ceresoli, Michele Reni, Giuseppe Chiesa, et al.
Acta Oncologica (Stockholm, Sweden)|May 21, 2010
Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologiesGiulia Sangalli, Paolo Passoni, Giovanni M Cattaneo, et al.
The British Journal of Radiology|August 26, 2016
Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary studyMassimo Venturini, Claudio Sallemi, Giulia Agostini, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 12, 2018
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE studyCarlo Lazzaro, Carlo Barone, Francesco Caprioni, et al.
Pageof 24